Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation

Nutrition Research

Volumn 32, Issue 3, 2012, Pages 218-228

  Choi, Eun Hye ^a   Yang, Hyun Pil ^b   Chun, Hyang Sook ^a  

^a Korea Food Research Institute   (South Korea)

^b Technical R and D Center   (South Korea)

Author keywords

Adipogenesis; Chitooligosaccharide; Gene expression; High fat diet; Inflammation; Obesity

Indexed keywords

ANTIOBESITY AGENT; CHITOSE OLIGOSACCHARIDE; COMPLEMENTARY DNA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CALORIC INTAKE; CATHEPSIN K GENE; CELL SIZE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DNA MICROARRAY; DRUG MECHANISM; EPIDIDYMIS; EXPERIMENTAL MOUSE; GENE EXPRESSION; HISTOPATHOLOGY; LIPID ANALYSIS; LIPID DIET; MALE; MARKER GENE; MATRIX METALLOPROTEINASE 12 GENE; MATRIX METALLOPROTEINASE 13 GENE; MATRIX METALLOPROTEINASE 14 GENE; MATRIX METALLOPROTEINASE 3 GENE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TISSUE INHIBITOR OF METALLOPROTEINASE 1 GENE; WEIGHT GAIN;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; ANTI-OBESITY AGENTS; CHITOSAN; CYTOKINES; DIET, HIGH-FAT; DIETARY FATS; DIETARY SUPPLEMENTS; ENERGY INTAKE; GENE EXPRESSION; INFLAMMATION; LIPID METABOLISM; LIPIDS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MICROARRAY ANALYSIS; OBESITY; OLIGOSACCHARIDES; WEIGHT GAIN;

MUS;

EID: 84859123648     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2012.02.004     Document Type: Article

References (48)

1. Visscher T.L., Seidell J.C. The public health impact of obesity. Annu Rev Public Health 2001, 22:355-375.
2. Marques B.G., Hausman D.B., Martin R.J. Association of fat cell size and paracrine growth factors in development of hyperplastic obesity. Am J Physiol 1998, 275:R1898-R1908.
3. Vázquez-Vela M.E.F., Torres N., Tovar A.R. White adipose tissue as endocrine organ and its role in obesity. Arch Med Res 2008, 39:715-728.
4. Rahman A., Kumar S.G., Yun J.W. Proteome analysis in adipose tissue of ob/ob mice in response to chitosan oligosaccharides treatment. Biotechnol Bioproc Eng 2010, 15:559-571.
5. Neyrinck A.M., Bindels L.B., De Backer F., Pachikian B.D., Cani P.D., Delzenne N.M. Dietary supplementation with chitosan derived from mushrooms changes adipocytokines profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action. Int Immunopharmacol 2009, 9:767-773.
6. Kim S., Jin Y., Choi Y., Park T. Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochem Pharmacol 2011, 81:1343-1351.
7. Ravie Kumar M.N.V. A review of chitin and chitosan applications. React Funct Polym 2000, 46:1-27.
8. Aranaz I., Mengíbar M., Harris R., Paños I., Miralles B., Acosta N., et al. Functional characterization of chitin and chitosan. Curr Chem Biol 2009, 3:203-230.
9. Rhoades J., Gibson G., Formentin K., Beer M., Rastall R. Inhibition of the adhesion of enteropathogenic Escherichia coli strains to HT-29 cells in culture by chito-oligosaccharides. Carbohydr Polym 2006, 64:57-59.
10. Vishu Kumar A.B., Varadaraj M.C., Gowda L.R., Tharanathan R.N. Characterization of chito-oligosaccharides prepared by chitosanolysis with the aid of papain and pronase, and their bactericidal action against Bacillus cereus and Escherichia coli. Biochem J 2005, 391:167-175.
11. Okamoto Y., Inoue A., Miyatake K., Ogihara K., Shigemasa Y., Minami S. Effects of chitin/chitosan and their oligomers/monomers on migrations of macrophages. Macromol Biosci 2003, 3:587-590.
12. Wang Z., Zheng L., Yang S., Niu R., Chu E., Lin X. N-acetylchitooligosaccharide is a potent angiogenic inhibitor both in vivo and in vitro. Biochem Biophys Res Commun 2007, 357:26-31.
13. Wu H., Yao Z., Bai X., Du Y., Lin B. Anti-angiogenic activities of chitooligosaccharides. Carbohydr Polym 2008, 73:105-110.
14. Hayashi K., Ito M. Antidiabetic action of low molecular weight chitosan in genetically obese diabetic KK-Ay mice. Biol Pharm Bull 2002, 25:188-192.
15. Sumiyoshi M., Kimura Y. Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet long-term in mice. J Pharm Pharmacol 2006, 58:201-207.
16. Cho E.J., Rahman M.A., Kim S.W., Baek Y.M., Hwang H.J., Oh J.Y., et al. Chitosan oligosaccharides inhibit adipogenesis in 3T3-L1 adipocytes. J Microbiol Biotechnol 2008, 18:80-87.
17. Tschöp M., Heiman M.L. Rodent obesity models: an overview. Exp Clin Endocrinol Diabetes 2001, 109:307-319.
18. Boden G. Interaction between free fatty acids and glucose metabolism. Curr Opin Clin Nutr Metab Care 2002, 5:545-549.
19. Buettner R., Schölmerich J., Bollheimer L.C. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 2007, 15:798-808.
20. Hariri N., Thibault L. High-fat diet-induced obesity in animal models. Nutr Res Rev 2010, 23:270-299.
21. Li S., Zhang H.Y., Hu C.C., Lawrence F., Gallagher K.E., Surapaneni A., et al. Assessment of diet-induced obese rats as an obesity model by comparative functional genomics. Obesity 2008, 16:811-818.
22. López I.P., Marti A., Milagro F.I., Zulet Md Mde L., Moreno-Aliaga M.J., Martinez J.A., et al. DNA microarray analysis of genes differentially expressed in diet-induced (cafeteria) obese rats. Obes Res 2003, 11:188-194.
23. Kim Y., Park T. DNA microarrays to define and search for genes associated with obesity. Biotechnol J 2010, 5:99-112.
24. Chae S.Y., Jang M.K., Nah J.W. Influence of molecular weight on oral absorption of water soluble chitosans. J Control Release 2005, 102:383-394.
25. Zeng L., Qin C., Wang W., Chi W., Li W. Absorption and distribution of chitosan in mice after oral administration. Carbohydr Polymers 2008, 71:435-440.
26. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
27. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
28. Bligh E.G., Dyer W.J. A rapid method for total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
29. Gallou-Kabani C., Vigé A., Gross M.S., Rabès J.P., Boileau C., Larue-Achagiotis C., et al. C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity 2007, 15:1996-2005.
30. Kumar S.G., Rahman M.A., Lee S.H., Hwang H.S., Kim H.A., Yun J.W. Plasma proteome analysis for anti-obesity and anti-diabetic potentials of chitosan oligosaccharides in ob/ob mice. Proteomics 2009, 9:2149-2162.
31. Yao H.T., Huang S.Y., Chiang M.T. A comparative study on hypoglycemic and hypocholesterolemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats. Food Chem Toxicol 2008, 46:1525-1534.
32. Bahar B., O'Doherty J.V., Sweeney T. A potential role of IL-6 in the chito-oligosaccharide-mediated inhibition of adipogenesis. Br J Nutr 2011, 106:1142-1153.
33. LeHoux J.G., Grondin F. Some effects of chitosan on liver function in the rat. Endocrinol 1993, 132:1078-1084.
34. Kim S.J., Kang S.Y., Park S.L., Shin T., Ku Y.H. Effects of chitooligosaccharides on liver function in the mouse. Kor J Food Sci Technol 1998, 30:693-696.
35. Ikeda I., Sugano M., Yoshida K., Sasaki E., Iwamoto Y., Hatano K. Effects of chitosan hydrolysates on lipid absorption and on serum and liver lipid concentration in rats. J Agric Food Chem 1993, 41:431-435.
36. Zhou K., Xia W., Zhang C., Yu L. In vitro binding of bile acids and triglycerides by selected chitosan preparations and their physico-chemical properties. LWT Food Sci Technol 2006, 39:1087-1092.
37. Ju C., Yue W., Yang Z., Zhang Q., Yang X., Lin Z., et al. Antidiabetic effect and mechanism of chitooligosaccharides. Biol Pharm Bull 2010, 33:1511-1516.
38. Liu S.H., Chang Y.H., Chinag M.T. Chitosan reduces gluconeogenesis and increases glucose uptake in skeletal muscle in streptozotocin-induced diabetic rats. J Agric Food Chem 2010, 58:5795-5800.
39. Scarpace P., Zhang Y. Leptin resistance: a predisposing factor for diet-induced obesity. Am J Physiol Integr Comp Physiol 2009, 296:R493-500.
40. Gregoire F.M., Smas C.M., Sul H.S. Understanding adipocyte differentiation. Physiol Rev 1998, 78:783-809.
41. Kubo Y., Kaidzu S., Nakajima I., Takenouchi K., Nakamura F. Organization of extracellular matrix components during differentiation of adipocytes in long-term culture. In Vitro Cell Dev Biol Anim 2000, 36:38-44.
42. Christianens V., Lijnen H.R. Role of the fibrinolytic and matrix metalloproteinase systems in development of adipose tissue. Arch Physiol Biochem 2006, 112:254-259.
43. Maquoi E., Munaut C., Colige A., Collen D., Lijnen H.R. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 2002, 51:1093-1101.
44. Lijnen H.R., Maquoi E., Hansen L.B., Van Hoef B., Frederix L., Collen D. Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol 2002, 22:374-379.
45. Bourlier V., Zakaroff-Girard A., De Barros S., Pizzacalla C., de Saint Front V.D., Lafontan M., et al. Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation. J Pharmacol Exp Ther 2005, 312:1272-1279.
46. Xiao Y., Junfeng H., Tianhong L., Lu W., Shulin C., Yu Z., et al. Cathepsin K in adipocyte differentiation and its potential role in the pathogenesis of obesity. J Clin Endocrinol Metab 2006, 91:4520-4527.
47. Li J., Yu X., Pan W., Uoger R.H. Gene expression profile of rat adipose tissue at the onset of high-fat-diet obesity. Am J Physiol Endocrinol Metab 2002, 282:E1334-E1341.
48. Lucas S., Verwaerde C., Wolowczuk I. Is the adipose tissue the key road to inflammation?. Immunol Immunogenet Insights 2009, 1:3-14.